Inoue M - Search Results

1

Outcome of 125 children with chronic myelogenous leukemia who received transplants from unrelated donors: the Japan Marrow Donor Program.

Muramatsu H, Kojima S, Yoshimi A, Atsuta Y, Kato K, Nagatoshi Y, Inoue M, Koike K, Kawase T, Ito M, Kurosawa H, Tanizawa A, Tono C, Hamamoto K, Hotta N, Watanabe A, Morishima Y, Kawa K, Shimada H. Muramatsu H, et al. Among authors: inoue m. Biol Blood Marrow Transplant. 2010 Feb;16(2):231-8. doi: 10.1016/j.bbmt.2009.09.022. Epub 2009 Sep 30. Biol Blood Marrow Transplant. 2010. PMID: 19800016 Free article.

2

Human leucocyte antigen-Cw-specific cytotoxic T lymphocytes generated from naive cord blood used for cord blood stem cell transplantation.

Yazaki M, Takahashi T, Mizutani K, Ito Y, Wakiguchi H, Inoue M, Kawa K, Kato K, Kato T, Saito H, Togari H. Yazaki M, et al. Among authors: inoue m. Br J Haematol. 2002 Jun;117(4):893-8. doi: 10.1046/j.1365-2141.2002.03504.x. Br J Haematol. 2002. PMID: 12060128 Free article.

3

Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.

Kawa K, Okamura T, Yasui M, Sato E, Inoue M. Kawa K, et al. Among authors: inoue m. Crit Rev Oncol Hematol. 2002 Dec;44(3):251-7. doi: 10.1016/s1040-8428(02)00116-6. Crit Rev Oncol Hematol. 2002. PMID: 12467965 Review.

4

Megatherapy with hematopoietic stem cell rescue as a preoperative treatment in unresectable pediatric malignancies.

Oue T, Kubota A, Okuyama H, Kawahara H, Inoue M, Yagi K, Kawa K. Oue T, et al. Among authors: inoue m. J Pediatr Surg. 2003 Jan;38(1):130-3; discussion 130-3. doi: 10.1053/jpsu.2003.50026. J Pediatr Surg. 2003. PMID: 12592635

5

Autologous hematopoietic stem cell transplantation for 3 patients with severe juvenile rheumatoid arthritis.

Kishimoto T, Hamazaki T, Yasui M, Sasabe M, Okamura T, Sakata N, Inoue M, Yagi K, Kawa K. Kishimoto T, et al. Among authors: inoue m. Int J Hematol. 2003 Dec;78(5):453-6. doi: 10.1007/BF02983820. Int J Hematol. 2003. PMID: 14704040

6

Clinical significance of minimal residual disease in childhood acute myeloid leukemia.

Miyamura T, Sakata N, Okamura T, Yasui M, Inoue M, Yagi K, Sako M, Komada Y, Matsuyama T, Oda M, Park YD, Kawa K. Miyamura T, et al. Among authors: inoue m. Int J Hematol. 2004 Apr;79(3):243-9. doi: 10.1532/ijh97.03113. Int J Hematol. 2004. PMID: 15168592

7

[Chronic active Epstein-Barr virus infection treated with reduced intensity stem cell transplantation].

Sakata N, Sato E, Sawada A, Yasui M, Inoue M, Kawa K. Sakata N, et al. Among authors: inoue m. Rinsho Ketsueki. 2004 May;45(5):393-6. Rinsho Ketsueki. 2004. PMID: 15199749 Japanese.

8

Successful treatment of chemoresistant stage 3 neuroblastoma using irinotecan as a single agent.

Inagaki J, Yasui M, Sakata N, Inoue M, Yagi K, Kawa K. Inagaki J, et al. Among authors: inoue m. J Pediatr Hematol Oncol. 2005 Nov;27(11):604-6. doi: 10.1097/01.mph.0000187430.60240.09. J Pediatr Hematol Oncol. 2005. PMID: 16282892

9

[Diagnosis and treatment of hemophagocytic syndrome].

Kawa K, Sakata A, Takeshita Y, Inoue M. Kawa K, et al. Among authors: inoue m. Rinsho Ketsueki. 2005 Jun;46(6):418-23. Rinsho Ketsueki. 2005. PMID: 16447723 Review. Japanese. No abstract available.

10

NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect.

Sawada A, Sato E, Koyama M, Higuchi B, Kusuki S, Kim JY, Takeshita Y, Sakata A, Sakata N, Okamura T, Yasui M, Inoue M, Kawa K. Sawada A, et al. Among authors: inoue m. Am J Hematol. 2006 Aug;81(8):576-81. doi: 10.1002/ajh.20659. Am J Hematol. 2006. PMID: 16823820 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,462 results

Search Page